TRIPLE EXPRESSOR LYMPHOMA IN A KIDNEY TRANSPLANT PATIENT
Evolución de un Linfoma No Hodgkin “Triple Expressor” en un paciente transplantado renal con quimioterapia DA-R-EPOCH. Caso Clínico
Author
Aránguiz, Natalia; Servicio de Medicina, Sección Hematología, Hospital Dr. Gustavo Fricke, Viña del Mar, Chile.
Servicio de Hemato-Oncología, Hospital Naval A Nef, Viña del Mar, Chile.
Vega, Jorge; Escuela de Medicina Universidad de Valparaíso; Hospital Naval A. Nef; Hospital Dr. Gustavo Fricke
Abstract
Patients transplanted from solid organs have an increased risk of cancer, especially lymphomas. Lymphomas correspond to 4 to 5% of malignant neoplasms in the general population and in solid organ transplant patients it reaches an incidence of 21%. The incidence of non-Hodgkin lymphomas is 10 times higher than in the non-transplanted population. We report the case of a 68-year-old man with a kidney transplant who 6 years after transplantation, developed a non-Hodgkin diffuse of large cells B lymphoma with lymph node and pulmonary involvement, with markers of very poor prognosis (triple MYC expressor, BCL2 and BCL6). and its evolution with chemotherapy with DA R EPOCH. Patients transplanted from solid organs have an increased risk of cancer, especially lymphomas. Lymphomas correspond to 4 to 5% of malignant neoplasms in the general population and in solid organ transplant patients it reaches an incidence of 21%. The incidence of non-Hodgkin lymphomas is 10 times higher than in the non-transplanted population. We report the case of a 68-year-old man with a kidney transplant who 6 years after transplantation, developed a non-Hodgkin diffuse of large cells B lymphoma with lymph node and pulmonary involvement, with markers of very poor prognosis (triple MYC expressor, BCL2 and BCL6). and its evolution with chemotherapy with DA R EPOCH.